FDA, Fraud, Public Health and Regulatory Compliance

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

FDA

Fraud

Public Health

Regulatory Compliance

Key Legal Issues Facing Telehealth Platforms, as Compliance Concerns Bubble for Platforms Launched During the Public Health Emergency

Health Care Law Brief

JUNE 2, 2022

The onset of the COVID-19 public health emergency (“PHE”) led to a surge in the use of telehealth by health care providers. For the reasons discussed below, DTC telehealth platforms should re-visit their compliance plans and be prepared for increased state and federal regulatory scrutiny. Provider Licenses.

Public Health

Public Health Compliance COVID-19 Licensing

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

DECEMBER 29, 2023

2023) ( Buckman preemption barred MDL asserting fraud on EPA), cert. United States Department of Health and Human Services , 58 F.4th Further, the plaintiffs’ arguments were based on scientific standards “not utilized by the FDA,” and thus preempted. The FDA’s five reviews of teratogenic risk all came to the same conclusion.

FDA

FDA US Department of Health and Human Services COVID-19 Informed Consent

Health Care Compliance Brief

Key Legal Issues Facing Telehealth Platforms, as Compliance Concerns Bubble for Platforms Launched During the Public Health Emergency

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Stay Connected